Adze-1.17.C.4.11

N/A

Report date: 2023/03/07 18:07:10

Base Information

Drug NameAdze-1.17.C.4.11
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionAnti-MCPDesmoglein-2 inhibitors
TargetsMembrane cofactor proteinDesmoglein-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdze Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdze Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A